FDA Inspection 1295920 — Dr. Rachna Arora, Ph.D.
The FDA completed an inspection of Dr. Rachna Arora, Ph.D. on Dec 15, 2025 in New Delhi. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Delhi (India)
Additional Details
Clinical BA/BE